Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Georgina Long

Tracked across 2 events · 134 articles · First seen Jun 07, 2026 · Last active Aug 20, 2026

Sentiment
60
Attention
8
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Tech
Impact: Georgina Long, co-medical director at The Australia Institute, collaborated with Richard Scolyer on groundbreaking melanoma research and designed the experimental brain cancer treatment for him. Her work is crucial to the ongoing clinical trials.
Jun 07, 2026 · 32 articles
8 60
Tech
Moderna and Merck & Co. announced on August 19, 2026, that their personalized mRNA cancer vaccine, Intismeran, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and secondary goals in a Phase 3 trial for…
Impact: As principal investigator, Long called the results a landmark moment for melanoma treatment, lending credibility to the findings.
Aug 19, 2026 · 102 articles
ERGEN INTELLIGENCE
Track Georgina Long live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.